Latest News for: mmj
Edit
Not All CBD Is Medicine: Why Medicare's Plan Could Undermine FDA Marijuana Science
ACCESSWIRE 21 Mar 2026
It is also the pathway followed - at great cost and over many years - by companies like MMJ International Holdings and its subsidiaries, including MMJ BioPharma Cultivation and MMJ BioPharma Labs, ...
Edit
Is Medicare Turning Seniors Into CBD Test Subjects?
ACCESSWIRE 15 Mar 2026
As Duane Boise, CEO of MMJ International Holdings, recently remarked.. "Patients deserve treatments backed by science, not guesswork ... The Problem ... As Duane Boise, CEO of MMJ International Holdings, recently remarked. ... Contact. ... MMJ International Holdings.
Edit
The $30 Billion CBD Question: Should Medicare Reimburse Cannabis Products Without FDA Approval?
ACCESSWIRE 11 Mar 2026
Companies pursuing the pharmaceutical pathway, including organizations such as MMJ International Holdings, have invested years advancing cannabinoid therapies through the ... MMJ International Holdings.
Edit
Medicare's CBD Gamble: Is Washington About to Bypass the FDA Drug Approval System for Marijuana Drugs?
ACCESSWIRE 10 Mar 2026
Companies such as MMJ International Holdings , along with its subsidiaries MMJ BioPharma Cultivation and MMJ BioPharma Labs , have spent years pursuing cannabinoid medicines through the traditional ...
Edit
"The Cannabis Industry's Medical Pivot: Why Most Companies Are Already Ten Years Behind."
ACCESSWIRE 09 Mar 2026
Edit
From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry's Reckoning Is Coming
ACCESSWIRE 07 Mar 2026
MMJ was built specifically for this architecture ... Why MMJ International Holdings Took the Hard Road. MMJ International Holdings focused on building cannabinoid medicines that could meet federal drug standards ... MMJ built medicine.
Edit
The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
ACCESSWIRE 06 Mar 2026
Edit
Pres. Trump's Marijuana Executive Mandate Accelerates MMJ International Holdings Federal Alignment Toward Pharmaceutical
ACCESSWIRE 05 Mar 2026
Rather than relying on variable botanical flower, MMJIH developed standardized pharmaceutical soft-gel capsules (MMJ-001 and MMJ-002) ... MMJ was built specifically for this architecture ... MMJ International Holdings is not adapting to Schedule III.
Edit
In Spite of Trump's Marijuana Executive Order, FDA Hemp and Marijuana Botanical Guidance Will Prevail
ACCESSWIRE 30 Dec 2025
What remains standing is the pathway that MMJ International Holdings chose in 2018 ... And MMJ completed it. MMJ's Seven-Year Record ... MMJ now has two fully developed drug candidates-MMJ-001 and MMJ-002-ready for FDA clinical advancement ... This is MMJ's lane.
Edit
DEA Marijuana Year in Review 2025: President Trump Fixing DEA?
ACCESSWIRE 30 Dec 2025
At the center of this failure is MMJ International Holdings, MMJ BioPharma Cultivation and MMJ BioPharma Labs, all U.S ... MMJ Did Everything the Federal Government Asked-And Was Punished for It. MMJ followed the hard path. ... MMJ built a real drug.
Edit
President Trump's Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else
ACCESSWIRE 27 Dec 2025
About MMJ International Holdings. MMJ International Holdings, Inc ... MMJ has manufactured validated, reproducible final dose form soft-gel capsules under FDA guidance for use in clinical trials targeting Huntington's Disease and Multiple Sclerosis.
Edit
A Christmas Message to the DEA's Diversion Anti Marijuana Cabal
ACCESSWIRE 26 Dec 2025
WASHINGTON, DC / ACCESS Newswire / December 26, 2025 / ... , , , Thomas Cook, and ... The result was not abstract. Patients with Huntington's Disease, a fatal neurodegenerative disorder with no cure ... Control ... MMJ is represented by ... MMJ International Holdings.
Edit
Trump’s Marijuana Schedule III Order Launches a Federally Regulated Healthcare Sector
ACCESSWIRE 23 Dec 2025
/ ACCESS Newswire / December 22, 2025 / MMJ International Holdings, MMJ BioPharma Cultivation and MMJ BioPharma Labs ("MMJ"), a pioneer in pharmaceutical-grade cannabinoid drug development, today ...
Edit
Corsicana Daily Sun
21 Dec 2025
After Trump's Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ's ...
Corsicana Daily Sun
21 Dec 2025
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts? ....
Edit
After Trump's Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ's Writ of Mandamus?
Pharmiweb 20 Dec 2025
At the center of this moment is MMJ International Holdings, MMJ BioPharma Labs and MMJ BioPharma Cultivation, a federally compliant pharmaceutical developer that has spent more than seven years ...
- 1
- 2
- Next page »